- Home
- ALEC vs OBIO Comparison
ALEC vs OBIO Comparison
Compare ALEC & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | OBIO |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.7M | 246.2M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALEC | OBIO |
|---|---|---|
| Price | $2.72 | $4.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $4.83 | ★ $14.25 |
| AVG Volume (30 Days) | ★ 614.7K | 130.9K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.13 |
| EPS | N/A | ★ N/A |
| Revenue | $21,045,000.00 | ★ $33,482,000.00 |
| Revenue This Year | $18.36 | N/A |
| Revenue Next Year | N/A | $12.43 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1169.22 |
| 52 Week Low | $0.98 | $2.20 |
| 52 Week High | $3.40 | $5.42 |
Technical Indicators
Market Signals| Indicator | ALEC | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 66.10 | 48.11 |
| Support Level | $1.89 | $4.02 |
| Resistance Level | $3.34 | $4.88 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 96.68 | 36.72 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.